All Articles
Two oral health experts offer a thorough exploration of bone marrow transplants and how they relate to the mouth, with many tips for maintaining proper oral care during and after a transplant. Read More ›
By Peter Smith
Peter Smith painted most of his life, but his paintings gained a new importance and perspective after his multiple myeloma diagnosis. Read More ›
Dr. Garcia-Manero, an expert on myelodysplastic syndromes, discusses this group of disorders representing a misunderstood and often ignored type of blood cancer. He explains everything from risk factors to early symptoms and treatment options.
Read More ›
In January 2021, the FDA approved a new indication for Xalkori (crizotinib), an oral ALK inhibitor, for the treatment of young patients who are diagnosed with relapsed or refractory systemic anaplastic large-cell lymphoma and ALK mutation. Xalkori was previously approved for metastatic lung cancer and ALK or ROS1 mutation. Read More ›
In December 2020, the FDA approved Xpovio (selinexor), for use in combination with the proteasome inhibitor Velcade (bortezomib) and the steroid dexamethasone, for the treatment of adults with multiple myeloma who have received at least 1 previous therapy. Xpovio was previously approved for several types of lymphoma. Read More ›
Two integrative medicine experts explain the benefits of yoga practice for patients with cancer and their caregivers. Read More ›
The social isolation of the COVID-19 pandemic has left those with cancer feeling more left out than ever. Finding companionship and building close relationships, whether in person or virtually, is essential to overall well-being. Read More ›
